More
knowledge –
Powered
by science
Idorsia aims to be Europe’s leading biopharmaceutical company, with a strong scientific core. We provide regular updates on the progress being made towards this goal. This section of the website provides journalists with additional material to support the generation of articles.
News
Events
| Event | When |
| Bryan Garnier European Healthcare Conference | November 16, 2020 |
| Jefferies London Healthcare Conference | November 17-18, 2020 |
| Credit Suisse Swiss Equity Conference | November 20, 2020 |
| J.P. Morgan Healthcare conference | January 11-12, 2021 |
| BofA Securities SMID Cap Conference | January 12-13, 2021 |
| Baader Helvea Swiss Equities Conference | January 14, 2021 |
| Octavian Seminar Flims | January 14-17, 2021 |
| Full-Year 2020 Financial Results reporting* | February 4, 2021 |
| First Quarter 2021 Financial Results reporting* | April 22, 2021 |
| Annual General Meeting of Shareholders | May 12, 2021 |
| Half-Year 2021 Financial Results reporting* | July 27, 2021 |
*We will be in a silent period for 10 days ahead of the financial reporting.
Stay informed
Idorsia offers an electronic ‘Stay Informed’ service where subscribers can automatically receive updates via e-mail or SMS alert.
Social Media
Idorsia is active on social media – follow our channels to get a more personal view on the company.
Media center
Idorsia provides images, fact sheets and B-roll to download or support you with your article.
Contact
Andrew C. Weiss
Senior Vice President, Head of Investor Relations and Corporate Communications
Media Relations
Resources in German
Als schweizerisches Unternehmen stellen wir interessierten Personen auf dieser Seite wesentliche Informationen über unser Unternehmen in deutscher Sprache zur Verfügung.